stockrow
Friday 6 November 2026
Export MCK’s income statement to Excel — free account
McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.
- Revenue
- +7.57%
- EPS
- +24.5%
- Free cash flow
- +32.5%
- Total debt
- +7.08%
Quarter to September 2026, against a year earlier
1,061.69
10.31
−0.96%
Follow MCK
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
21.49 | 20.13 | 22.40 | 23.49 |
+8 more quarters Free account |
P/S ratio |
0.24 | 0.22 | 0.27 | 0.25 | |
P/FCF ratio |
14.46 | 14.60 | 19.77 | 10.48 | |
P/Operating CF |
32.34 | (407.68) | 31.27 | 82.03 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.25 | 0.24 | 0.28 | 0.28 | |
EV/EBITDA |
14.27 | 13.68 | 16.51 | 17.32 | |
EV/Operating CF |
14.20 | 14.49 | 18.62 | 10.47 | |
EV/FCF |
15.51 | 16.16 | 21.18 | 11.38 | |
Quick Ratio |
0.50 | 0.50 | 0.48 | 0.46 | |
Current Ratio |
0.90 | 0.89 | 0.85 | 0.88 | |
Net Debt/EBITDA |
4.02 | 6.36 | 3.26 | 4.82 | |
Debt/Assets |
14.92% | 16.74% | 14.11% | 13.85% | |
Debt/Equity |
(3.85) | (3.83) | (6.54) | (12.94) | |
Asset Turnover |
4.75 | 4.85 | 5.12 | 5.13 | |
Operating CF/Net income |
2.52 | (0.36) | 2.03 | 1.04 | |
Capex/Depreciation |
(0.62) | (0.78) | (0.94) | (0.93) | |
Interest Coverage |
15.28 | 17.13 | 35.25 | 25.70 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.04% | 2.15% | 1.87% | 1.91% | |
Intangible Assets out of Total Assets |
0.16 | 0.17 | 0.19 | 0.18 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.29) | (0.33) | (0.25) | (0.25) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
4.65% | 4.97% | 4.47% | 4.26% | |
Free Cash Flow Yield |
6.92% | 6.85% | 5.06% | 9.54% | |
Revenue per Share |
954.06 | 887.78 | 779.09 | 861.67 | |
Operating CF per Share |
26.40 | (1.85) | 27.68 | 10.00 | |
Capex per Share |
(1.06) | (1.28) | (1.50) | (1.42) | |
Free Cash Flow per Share |
25.34 | (3.13) | 26.18 | 8.58 | |
Cash per Share |
56.13 | 43.50 | 32.16 | 24.02 | |
Shareholders Equity per Share |
(30.77) | (32.55) | (14.38) | (7.31) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(30.77) | (32.55) | (14.38) | (7.31) | |
Free Cash Flow |
2,947.00 | (372.00) | 3,236.00 | 1,057.00 | |
Working Capital |
(7,711.00) | (7,519.00) | (9,807.00) | (8,434.00) | |
Capital Expenditures |
(123.00) | (152.00) | (185.00) | (175.00) | |
Net Current Asset Value |
(29,217.00) | (29,357.00) | (26,890.00) | (25,394.00) | |
EV/EBIT |
15.92 | 15.29 | 18.45 | 19.42 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
14.84 | 13.81 | 17.22 | 17.88 | |
| Other line items | |||||
Average Receivables |
29,546.00 | 29,237.00 | 26,814.00 | 27,022.00 | |
Average Payables |
64,349.50 | 60,796.00 | 57,651.50 | 55,186.00 | |
Average Inventory |
27,175.50 | 25,662.00 | 23,604.00 | 25,452.00 | |
Average Assets |
88,241.50 | 84,820.50 | 78,731.50 | 77,635.50 | |
Average Common Equity |
(2,467.00) | (2,726.00) | (1,735.50) | (1,802.50) |
Columns are period end dates · fundamentals updated 6 Nov 2026